{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:24:10Z","timestamp":1763137450035,"version":"3.45.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HE23C002800"],"award-info":[{"award-number":["HE23C002800"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02087-9","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:19:55Z","timestamp":1763137195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of metformin and alogliptin combination therapy versus metformin monotherapy in patients with type 2 diabetes: an emulated target trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Jaehyeong","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejun","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YongHyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahye","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dosang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Youl","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"1","key":"2087_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262.","journal-title":"Signal Transduct Target Ther"},{"issue":"10397","key":"2087_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"},{"key":"2087_CR3","doi-asserted-by":"crossref","unstructured":"Hamblin PS, Russell AW, Talic S, Zoungas S. The growing range of complications of diabetes mellitus. Trends Endocrinol Metab 2025.","DOI":"10.1016\/j.tem.2024.12.006"},{"issue":"Suppl 1","key":"2087_CR4","first-page":"S20","volume":"47","author":"2","year":"2024","unstructured":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"2","key":"2087_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4093\/dmj.2023.0225","volume":"48","author":"YS Yang","year":"2024","unstructured":"Yang YS, Kim NH, Baek JH, et al. Real-World treatment patterns according to clinical practice guidelines in patients with type 2 diabetes mellitus and established cardiovascular disease in korea: Multicenter, Retrospective, observational study. Diabetes Metab J. 2024;48(2):279\u201389.","journal-title":"Diabetes Metab J"},{"issue":"10","key":"2087_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1463-1326.2012.01620.x","volume":"14","author":"Y Seino","year":"2012","unstructured":"Seino Y, Miyata Y, Hiroi S, Hirayama M, Kaku K. Efficacy and safety of alogliptin added to Metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study. Diabetes Obes Metab. 2012;14(10):927\u201336.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2087_CR7","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4093\/dmj.2024.0485","volume":"48","author":"YH Park","year":"2024","unstructured":"Park YH, Sohn M, Lim S. Two-Year therapeutic efficacy and safety of initial triple combination of Metformin, Sitagliptin, and empagliflozin in Drug-Na\u00efve type 2 diabetes mellitus patients (Diabetes metab J 2024;48:253\u2009\u2013\u200964). Diabetes Metab J. 2024;48(5):1012\u20133.","journal-title":"Diabetes Metab J"},{"key":"2087_CR8","doi-asserted-by":"crossref","unstructured":"Ladwa M, Bello O, Hakim O et al. Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men. BMJ Open Diabetes Res Care 2021; 9(1).","DOI":"10.1136\/bmjdrc-2020-002034"},{"issue":"1","key":"2087_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14205","volume":"23","author":"L Ji","year":"2021","unstructured":"Ji L, Chan JCN, Yu M, et al. Early combination versus initial Metformin monotherapy in the management of newly diagnosed type 2 diabetes: an East Asian perspective. Diabetes Obes Metab. 2021;23(1):3\u201317.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"2087_CR10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/dc25-0355","volume":"48","author":"J Cho","year":"2025","unstructured":"Cho J, Woo S, Hwang SH, et al. A multimodal predictive model for chronic kidney disease and its association with vascular complications in patients with type 2 diabetes: model development and validation study in South Korea and the U.K. Diabetes Care. 2025;48(9):1562\u201370.","journal-title":"Diabetes Care"},{"issue":"3","key":"2087_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ibd\/izae131","volume":"31","author":"S Honap","year":"2025","unstructured":"Honap S, Danese S, Peyrin-Biroulet L. Target trial emulation: improving the quality of observational studies in inflammatory bowel disease using the principles of randomized trials. Inflamm Bowel Dis. 2025;31(3):843\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2087_CR12","doi-asserted-by":"publisher","first-page":"e181755","DOI":"10.1001\/jamanetworkopen.2018.1755","volume":"1","author":"R Vashisht","year":"2018","unstructured":"Vashisht R, Jung K, Schuler A, et al. Association of hemoglobin A1c levels with use of Sulfonylureas, dipeptidyl peptidase 4 Inhibitors, and Thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open. 2018;1(4):e181755\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2087_CR13","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758\u201364.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2087_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/jamia\/ocac158","volume":"30","author":"M Elkheder","year":"2023","unstructured":"Elkheder M, Gonzalez-Izquierdo A, Qummer Ul Arfeen M, et al. Translating and evaluating historic phenotyping algorithms using SNOMED CT. J Am Med Inf Assoc. 2023;30(2):222\u201332.","journal-title":"J Am Med Inf Assoc"},{"key":"2087_CR15","doi-asserted-by":"crossref","unstructured":"Care D. 2. Classification and diagnosis of diabetes: standards of care in. Diabetes Care 2023;46: S19.","DOI":"10.2337\/dc23-S002"},{"issue":"12","key":"2087_CR16","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","volume":"65","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia. 2022;65(12):1925\u201366.","journal-title":"Diabetologia"},{"key":"2087_CR17","doi-asserted-by":"crossref","unstructured":"Ortega E, Redondo-Ant\u00f3n J, D\u00edaz-Cerezo S, Rubio-de Santos M, Romera I. Glycaemic and weight control in people aged 65 or younger newly diagnosed with type 2 diabetes in Spain: insights from the PRIORITY-T2D study. Adv Therapy 2025: 1\u201315.","DOI":"10.1007\/s12325-025-03230-7"},{"issue":"1","key":"2087_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41598-020-57799-w","volume":"10","author":"T Geldof","year":"2020","unstructured":"Geldof T, Popovic D, Van Damme N, Huys I, Van Dyck W. Nearest neighbour propensity score matching and bootstrapping for estimating binary patient response in oncology: A Monte Carlo simulation. Sci Rep. 2020;10(1):964.","journal-title":"Sci Rep"},{"issue":"5","key":"2087_CR19","doi-asserted-by":"publisher","first-page":"e70364","DOI":"10.1002\/jmv.70364","volume":"97","author":"J Cho","year":"2025","unstructured":"Cho J, Park J, Son Y, et al. Post-Acute sequelae of COVID-19 on alopecia areata in individuals with mental illness in South Korea and japan: A binational Population-Based cohort study. J Med Virol. 2025;97(5):e70364.","journal-title":"J Med Virol"},{"key":"2087_CR20","first-page":"0","volume-title":"Unpaired t-tests","author":"Paired","year":"2013","unstructured":"Paired. In: Kilcoyne A, O\u2019Connor D, Ambery P, Kilcoyne A, Ambery P, O\u2019Connor D, editors. and Unpaired t-tests. Pharmaceutical Medicine: Oxford University Press; 2013. p. 0."},{"issue":"12","key":"2087_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S2468-1253(24)00226-7","volume":"9","author":"G Ndow","year":"2024","unstructured":"Ndow G, Shimakawa Y, Leith D, et al. Clinical outcomes of untreated adults living with chronic hepatitis B in the gambia: an analysis of data from the prospective PROLIFICA cohort study. Lancet Gastroenterol Hepatol. 2024;9(12):1133\u201346.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2087_CR22","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2589-7500(23)00208-X","volume":"6","author":"X Jiang","year":"2024","unstructured":"Jiang X, Hoffmeister M, Brenner H, et al. End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study. Lancet Digit Health. 2024;6(1):e33\u201343.","journal-title":"Lancet Digit Health"},{"issue":"8","key":"2087_CR23","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41562-024-01895-8","volume":"8","author":"S Kim","year":"2024","unstructured":"Kim S, Lee H, Lee J, et al. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat Hum Behav. 2024;8(8):1530\u201344.","journal-title":"Nat Hum Behav"},{"issue":"5","key":"2087_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/dom.12875","volume":"19","author":"L Ji","year":"2017","unstructured":"Ji L, Li L, Kuang J, et al. Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial. Diabetes Obes Metab. 2017;19(5):754\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"2087_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s40264-019-00857-8","volume":"42","author":"K Kaku","year":"2019","unstructured":"Kaku K, Kisanuki K, Shibata M, Oohira T. Benefit-Risk assessment of alogliptin for the treatment of type 2 diabetes mellitus. Drug Saf. 2019;42(11):1311\u201327.","journal-title":"Drug Saf"},{"issue":"36","key":"2087_CR26","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.3346\/jkms.2021.36.e230","volume":"36","author":"KA Lee","year":"2021","unstructured":"Lee KA, Jin HY, Kim YJ, Im YJ, Kim EY, Park TS. Treatment patterns of type 2 diabetes assessed using a common data model based on electronic health records of 2000\u20132019. J Korean Med Sci. 2021;36(36):e230.","journal-title":"J Korean Med Sci"},{"key":"2087_CR27","doi-asserted-by":"publisher","first-page":"104803","DOI":"10.1016\/j.ebiom.2023.104803","volume":"96","author":"J Zheng","year":"2023","unstructured":"Zheng J, Xu M, Yang Q, et al. Efficacy of Metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study. EBioMedicine. 2023;96:104803.","journal-title":"EBioMedicine"},{"issue":"8","key":"2087_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol. 2023;19(8):460\u201376.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2087_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13098-024-01412-x","volume":"16","author":"LM Pechmann","year":"2024","unstructured":"Pechmann LM, Pinheiro FI, Andrade VFC, Moreira CA. The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its Pharmacological Inhibition on bone metabolism: a review. Diabetol Metab Syndr. 2024;16(1):175.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2087_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234.","journal-title":"Signal Transduct Target Ther"},{"key":"2087_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2019.01.025","volume":"149","author":"D Farah","year":"2019","unstructured":"Farah D, Leme GM, Eliaschewitz FG, Fonseca MCM. A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;149:47\u201363.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"2087_CR32","doi-asserted-by":"publisher","first-page":"107950","DOI":"10.1016\/j.jdiacomp.2021.107950","volume":"35","author":"J Grossman","year":"2021","unstructured":"Grossman J, Ward A, Crandell JL, Prahalad P, Maahs DM, Scheinker D. Improved individual and population-level HbA1c Estimation using CGM data and patient characteristics. J Diabetes Complications. 2021;35(8):107950.","journal-title":"J Diabetes Complications"},{"key":"2087_CR33","doi-asserted-by":"crossref","unstructured":"Liu X, Yang X, Wu N. Relationship between glycosylated hemoglobin variability and the severity of coronary artery disease in patients with type 2 diabetes mellitus. J Diabetes Res. 2024;9958586.","DOI":"10.1155\/2024\/9958586"},{"issue":"5","key":"2087_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/jdi.12801","volume":"9","author":"JY Jeon","year":"2018","unstructured":"Jeon JY, Lee SJ, Lee S, et al. Failure of monotherapy in clinical practice in patients with type 2 diabetes: the Korean National diabetes program. J Diabetes Investig. 2018;9(5):1144\u201352.","journal-title":"J Diabetes Investig"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02087-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02087-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02087-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:19:56Z","timestamp":1763137196000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02087-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02087-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this emulated target trial received approval from the Institutional Review Boards of the following institutions: Kyung Hee University Hospital (KHUH-2023-10-077), Keimyung University Dongsan Medical Center (DSMC 2024-02-056), Ewha Womans University Mokdong Hospital (SEUMC 2023-12-002-003), and Chonnam National University Hwasun Hospital (CNUHH-2024-012). All procedures adhered to the ethical standards of the Declaration of Helsinki. As this was a retrospective study using anonymized data, participant consent was waived under the approved protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}